{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:36:12Z","timestamp":1790361372832,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["14131052"],"award-info":[{"award-number":["14131052"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CEIRS","award":["HHSN27220140006C"],"award-info":[{"award-number":["HHSN27220140006C"]}]},{"name":"Theme Based Research Scheme","award":["T11-705\/14-N"],"award-info":[{"award-number":["T11-705\/14-N"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.antiviral.2018.05.007","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T19:08:49Z","timestamp":1526584129000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model"],"prefix":"10.1016","volume":"155","author":[{"given":"H.S.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise I.T.","family":"Kuok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy M.T.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-3209","authenticated-orcid":false,"given":"K.C.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenrie P.Y.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.antiviral.2018.05.007_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14787210.2017.1271712","article-title":"Update on therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)","volume":"15","author":"Al-Tawfiq","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.antiviral.2018.05.007_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijid.2013.12.003","article-title":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study","volume":"20","author":"Al-Tawfiq","year":"2014","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.antiviral.2018.05.007_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMsr1408795","article-title":"Middle East respiratory syndrome","volume":"376","author":"Arabi","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.antiviral.2018.05.007_bib4","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1128\/JVI.00009-13","article-title":"Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures","volume":"87","author":"Chan","year":"2013","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2018.05.007_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-2600(14)70158-4","article-title":"Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study","volume":"2","author":"Chan","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"14","key":"10.1016\/j.antiviral.2018.05.007_bib6","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.05.007_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virusres.2016.11.011","article-title":"Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model","volume":"228","author":"de Wilde","year":"2017","journal-title":"Virus Res."},{"issue":"Pt 8","key":"10.1016\/j.antiviral.2018.05.007_bib8","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1099\/vir.0.052910-0","article-title":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment","volume":"94","author":"de Wilde","year":"2013","journal-title":"J. Gen. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2018.05.007_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","volume":"19","author":"Falzarano","year":"2013","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.antiviral.2018.05.007_bib10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2006.08.027","article-title":"Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin a and interferon-\u03b1","volume":"131","author":"Henry","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.antiviral.2018.05.007_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01710-2016","article-title":"Tropism and innate host responses of influenza A\/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract","volume":"49","author":"Hui","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.antiviral.2018.05.007_bib12","volume":"vol. 38","author":"Inoue","year":"2003"},{"issue":"1","key":"10.1016\/j.antiviral.2018.05.007_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.antiviral.2018.05.007_bib14","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1073\/pnas.0710907105","article-title":"Role of the Akt pathway in mRNA translation of interferon-stimulated genes","volume":"105","author":"Kaur","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.antiviral.2018.05.007_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3947\/ic.2015.47.4.247","article-title":"The same Middle East respiratory syndrome-coronavirus (MERS-CoV) yet different outbreak patterns and public health impacts on the far East expert opinion from the rapid response team of the Republic of Korea","volume":"47","author":"Korean Society of Infectious, D., Korean Society for Healthcare-associated Infection, C., & Prevention","year":"2015","journal-title":"Infect. Chemother."},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2018.05.007_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2009.07.009","article-title":"Growth suppressive cytokines and the AKT\/mTOR pathway","volume":"48","author":"Kroczynska","year":"2009","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.antiviral.2018.05.007_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/diseases4030026","article-title":"Human coronaviruses: a review of virus\u2013host interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Diseases"},{"issue":"1","key":"10.1016\/j.antiviral.2018.05.007_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-3062.2010.00556.x","article-title":"Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes","volume":"13","author":"Liu","year":"2011","journal-title":"Transpl. Infect. Dis. Offic. J. Transplant. Soc."},{"issue":"11","key":"10.1016\/j.antiviral.2018.05.007_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.antiviral.2018.05.007_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJMe1308724","article-title":"Person-to-person spread of the MERS coronavirus--an evolving picture","volume":"369","author":"Perlman","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.antiviral.2018.05.007_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.antiviral.2018.05.007_bib22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.celrep.2015.03.056","article-title":"Central role of ULK1 in type I interferon signaling","volume":"11","author":"Saleiro","year":"2015","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.antiviral.2018.05.007_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071815","article-title":"Cyclosporin a inhibits rotavirus replication and restores interferon-beta signaling pathway in vitro and in vivo","volume":"8","author":"Shen","year":"2013","journal-title":"Plos One"},{"issue":"19","key":"10.1016\/j.antiviral.2018.05.007_bib24","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:27:11Z","timestamp":1759062431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218300949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":24,"alternative-id":["S0166354218300949"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.05.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}